|
Market Closed -
Nasdaq
07:00:00 29/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.9401 USD | +18.97% |
|
-7.83% | -15.31% |
| Market Cap | 30.51M 27.37M 25.31M 22.92M 42.82M 2.91B 43.34M 303M 121M 1.52B 114M 112M 4.83B | P/E 2024 |
-0.79x | P/E 2025 | -0.31x |
|---|---|---|---|---|---|
| Enterprise Value | 99.04M 88.86M 82.16M 74.41M 139M 9.43B 141M 982M 391M 4.94B 372M 364M 15.67B | EV / Sales 2024 |
2.12x | EV / Sales 2025 | 3.77x |
| Free-Float |
66.73% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CELU | Delayed | |
CBOE
| CELU | Real-time |
| 1 day | +18.97% | ||
| 1 week | -7.83% | ||
| Current month | -30.36% | ||
| 1 month | -32.85% | ||
| 3 months | +23.68% | ||
| 6 months | -9.61% | ||
| Current year | -15.31% |
| 1 week | 0.66 |  | 1.14 |
| 1 month | 0.66 | | 1.8 |
| Current year | 0.56 | | 2.55 |
| 1 year | 0.56 | | 2.55 |
| 3 years | 0.56 | | 7.97 |
| 5 years | 0.56 | | 131.86 |
| 10 years | 0.56 | | 134 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 01/01/2016 | |
John Sprague
DFI | Director of Finance/CFO | 67 | 27/02/2026 |
Anna Gosiewska
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 01/01/2016 | |
Peter Diamandis
BRD | Director/Board Member | 64 | 01/07/2017 |
Steven Gordon
BRD | Director/Board Member | 58 | 19/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/9/26 | Others | 6,425,301 | 26.8288% | |||
| 23/9/26 | Others | Director | 6,425,301 | 26.8288% | ||
| 23/9/26 | Others | 6,425,301 | 26.8288% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +18.97% | -7.83% | -52.99% | -55.02% | 25.64M | |
| +0.50% | +1.38% | +57.09% | +129.96% | 1,143B | |
| +0.86% | +5.14% | +45.00% | +86.15% | 647B | |
| -0.14% | +0.42% | +25.69% | +105.85% | 506B | |
| -0.05% | +1.73% | +52.74% | +67.74% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.06% | 350B | |
| +0.34% | +1.84% | +30.70% | +54.27% | 293B | |
| -0.45% | +1.19% | +2.89% | +26.08% | 265B | |
| +0.87% | +3.08% | +54.69% | +72.74% | 242B | |
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | |
| Average | +2.03% | -2.97% | +31.28% | +63.26% | 402.76B | |
| Weighted average by Cap. | +0.25% | +0.71% | +44.50% | +89.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 54.22M 48.65M 44.98M 40.73M 76.1M 5.16B 77.02M 538M 214M 2.7B 203M 199M 8.58B | 26.55M 23.82M 22.02M 19.95M 37.26M 2.53B 37.71M 263M 105M 1.32B 99.63M 97.53M 4.2B |
| Net income | -57.89M -51.94M -48.02M -43.49M -81.25M -5.51B -82.24M -574M -229M -2.89B -217M -213M -9.16B | -91.72M -82.29M -76.08M -68.9M -129M -8.74B -130M -910M -362M -4.57B -344M -337M -14.51B |
| Net Debt | 68.1M 61.1M 56.49M 51.16M 95.58M 6.49B 96.73M 675M 269M 3.39B 256M 250M 10.77B | 68.54M 61.49M 56.85M 51.49M 96.2M 6.53B 97.36M 680M 271M 3.42B 257M 252M 10.84B |
Employees
115
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | USD 0.9401 | +18.97% | 336,568 |
| 27/10/26 | USD 0.7902 | +5.36% | 219,290 |
| 26/10/26 | USD 0.7500 | -23.29% | 629,002 |
| 23/10/26 | USD 0.9777 | -6.89% | 145,347 |
| 22/10/26 | USD 1.050 | +2.94% | 144,726 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CELU Stock
Select your edition
All financial news and data tailored to specific country editions
